ArticleClinical pharmacokinetics2022

Population Pharmacokinetics of Abrocitinib in Healthy Individuals and Patients with Psoriasis or Atopic Dermatitis.

Jessica Wojciechowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.